►►Submit your paper by clicking the ABOVE RED TAG "ONLINE SUBMISSION".
►►Very important notification on publication fee
Effective February 2019, Cancer Biology & Medicine, as an open access journal, will charge a reasonable publication fee of $1,500/¥10,000 for each accepted article (all article types). No fees will be charged for invited articles.
Cancer Biology & Medicine is a peer-reviewed open-access journal published by the Chinese Anti-cancer Association (CACA), which is the leading professional society of oncology in China. Published quarterly, the journal provides innovative and significant information on the biological basis of cancer, cancer microenvironment, translational cancer research, and all aspects of clinical cancer research. The journal also publishes significant perspectives on indigenous cancer types in China. The scope covers the following topics:
● Cancer genetics
● Cancer and stem cell biology
● Molecular and clinical immunology
● Cancer prevention and epidemiology
● Cancer biomarkers
● Radiation oncology
● Oncology clinical trials
● Mechanisms of drug sensitivity and resistance
● Targeted therapy and immunotherapy
● Multidisciplinary treatment and personalized medicine
Author Benefits
● Easy submission via online system
● Efficient and professional peer review
● Rapid pre-print online publication
● No charge for publication and open access
● International visibility-All full texts are free in PubMed Central
Announcements
NEW IMPACT FACTOR 4.467 |
|
According to the Journal Citation Reports (2019), the IMPACT FACTOR (2018) of Cancer Biology & Medicine is 4.467, locating in Q1 area of Medicine, Research & Experimental category (ranking 33/136) and Q2 area of Oncology category (ranking 66/229). |
|
| Posted: 2019-06-25 | |
Breakthrough Summit |
|
2019 Breakthrough Summit will be held on October 11-13, 2019 in Bangkok, Thailand. Click here to visit its official website.
|
|
| Posted: 2019-05-22 | |
| More Announcements... |
Vol 16, No 2: May 2019
Table of Contents
Editorial
| Immunosuppressive checkpoint Siglec-15: a vital new piece of the cancer immunotherapy jigsaw puzzle | PDF HTML |
| Xiubao Ren | 205-210 |
Review
| The functional role of miRNAs and colorectal cancer: insights from a large population-based study | PDF HTML |
| Lila E. Mullany, Martha L. Slattery | 211-219 |
Original Article
| Dorsomorphin induces cancer cell apoptosis and sensitizes cancer cells to HSP90 and proteasome inhibitors by reducing nuclear heat shock factor 1 levels | PDF HTML |
| Na Li, Ting Wang, Zongmeng Li, et al. | 220-233 |
| Identification of anticancer drugs to radiosensitise BRAFwild- type and mutant colorectal cancer | PDF HTML |
| Rebecca Carter, Azadeh Cheraghchi-Bashi, Adam Westhorpe, et al. | 234-246 |
| Telmisartan induces melanoma cell apoptosis and synergizes with vemurafenib in vitro by altering cell bioenergetics | PDF HTML |
| Jelena Grahovac, Tatjana Srdić-Rajić, Juan Francisco Santibañez, et al. | 247-263 |
| Effects of palbociclib in oral squamous cell carcinoma and the role of PIK3CA in conferring resistance | PDF HTML |
| Nur Syafinaz Zainal, Bernard Kok Bang Lee, Zheng Wei Wong, et al. | 264-275 |
| Hepatitis B virus X protein enhances hepatocarcinogenesis by depressing the targeting of NUSAP1 mRNA by miR-18b | PDF HTML |
| Zhe Yang, Jiong Li, Guoxing Feng, et al. | 276-287 |
| Attenuated plasmodium sporozoite expressing MAGE-A3 induces antigen-specific CD8+ T cell response against lung cancer in mice | PDF HTML |
| Dong Zhou, Hong Zheng, Quanxing Liu, et al. | 288-298 |
| Cancer stem-like cells directly participate in vasculogenic mimicry channels in triple-negative breast cancer | PDF HTML |
| Huizhi Sun, Nan Yao, Siqi Cheng, et al. | 299-311 |
| Factors associated with upstaging in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy | PDF HTML |
| Jing Si, Benlong Yang, Rong Guo, et al. | 312-318 |
| Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers | PDF HTML |
| Andreas M. Luebke, Ali Attarchi-Tehrani, Jan Meiners, et al. | 319-330 |
| LAG-3 expression on tumor-infiltrating T cells in soft tissue sarcoma correlates with poor survival | PDF HTML |
| Yi Que, Zhixin Fang, Yuanxiang Guan, et al. | 331-340 |
| Prognostic model of survival outcomes in non-small cell lung cancer patients initiated on afatinib: pooled analysis of clinical trial data | PDF HTML |
| Ashley M. Hopkins, Adel Shahnam, Sasha Zhang, et al. | 341-349 |
| Adjuvant treatment for triple-negative breast cancer: a retrospective study of immunotherapy with autologous cytokine-induced killer cells in 294 patients | PDF HTML |
| Yuhan Zhang, Shuaibing Wang, Beibei Yang, et al. | 350-360 |
| Genetic polymorphisms and gastric cancer risk: a comprehensive review synopsis from meta-analysis and genome-wide association studies | PDF HTML |
| Jie Tian, Guanchu Liu, Chunjian Zuo, et al. | 361-376 |
| Cytosolic phospholipase A2α modulates cell-matrix adhesion via the FAK/paxillin pathway in hepatocellular carcinoma | PDF HTML |
| Piao Guo, Yuchao He, Lu Chen, et al. | 377-390 |
OUR FRIENDS
